POSELTINIB
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for POSELTINIB, covering 2025-12-08 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma [Phase 1]